EFFECTIVENESS OF PD-L1 INHIBITION AS A THERAPEUTIC OPTION OF CANCER IMMUNOTHERAPY IN PANCREATIC CANCER

被引:0
|
作者
Kameta, Eri
Shibata, Wataru
Sato, Takeshi
Sue, Soichiro
Maeda, Shin
机构
关键词
D O I
10.1016/S0016-5085(17)30942-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
993
引用
收藏
页码:S189 / S189
页数:1
相关论文
共 50 条
  • [1] RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy
    Byunghee Yoo
    Veronica Clavijo Jordan
    Patrick Sheedy
    Ann-Marie Billig
    Alana Ross
    Pamela Pantazopoulos
    Zdravka Medarova
    Scientific Reports, 9
  • [2] RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy
    Yoo, Byunghee
    Jordan, Veronica Clavijo
    Sheedy, Patrick
    Billig, Ann-Marie
    Ross, Alana
    Pantazopoulos, Pamela
    Medarova, Zdravka
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [3] PD-1/PD-L1 and immunotherapy for pancreatic cancer
    Feng, Mengyu
    Xiong, Guangbing
    Cao, Zhe
    Yang, Gang
    Zheng, Suli
    Song, Xujun
    You, Lei
    Zheng, Lianfang
    Zhang, Taiping
    Zhao, Yupei
    CANCER LETTERS, 2017, 407 : 57 - 65
  • [4] PD-L1 inhibition improves response of pancreatic cancer to radiotherapy
    Azad, A.
    D'Costa, Z.
    Lim, S. Y.
    Sansom, O.
    McKenna, W. G.
    Muschel, R.
    Fokas, E.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S133 - S133
  • [5] PD-L1: From cancer immunotherapy to therapeutic implications in multiple disorders
    Lee, Daeun
    Cho, Minjeong
    Kim, Eunseo
    Seo, Youngbin
    Cha, Jong-Ho
    MOLECULAR THERAPY, 2024, 32 (12) : 4235 - 4255
  • [6] PD-L1 Expression in Pancreatic Cancer
    Zheng, Lei
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (06):
  • [7] Contemporary clinical trials in pancreatic cancer immunotherapy targeting PD-1 and PD-L1
    Nagaraju, Ganji Purnachandra
    Malla, Rama Rao
    Basha, Riyaz
    Motofei, Ion G.
    SEMINARS IN CANCER BIOLOGY, 2022, 86 : 616 - 621
  • [8] PD-L1 as a Biomarker in Gastric Cancer Immunotherapy
    Cho, Yunjoo
    Ahn, Soomin
    Kim, Kyoung-Mee
    JOURNAL OF GASTRIC CANCER, 2025, 25 (01) : 177 - 191
  • [9] Mitochondrial PD-L1 modulates cancer immunotherapy
    Dai, Xiaoming
    Liu, Jing
    Wei, Wenyi
    CELL RESEARCH, 2023, 33 (05) : 335 - 336
  • [10] PD-L1 peptides in cancer immunoimaging and immunotherapy
    Du, Shiye
    Liu, Junzhi
    Zhang, Youjia
    Ge, Xiaoguang
    Gao, Shi
    Song, Jibin
    JOURNAL OF CONTROLLED RELEASE, 2025, 378 : 1061 - 1079